100 doses of Ebola drug available: Sarepta CEO
September 30, 2014 at 18:23 PM EDT
The company behind one of the most promising Ebola treatments has enough doses to handle about 100 patients, Sarepta Therapeutics CEO Chris Garabedian says.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.